Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses

被引:0
作者
Lei-Ping Zeng
Xing-Yi Ge
Cheng Peng
Wanbo Tai
Shibo Jiang
Lanying Du
Zheng-Li Shi
机构
[1] Chinese Academy of Sciences,CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology
[2] New York Blood Center,Lindsley F. Kimball Research Institute
[3] Fudan University,Key Laboratory of Medical Molecular Virology of MOE/MOH, School of Basic Medical Sciences
来源
Science China Life Sciences | 2017年 / 60卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1399 / 1402
页数:3
相关论文
共 66 条
[1]  
He Y.(2005)Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies J Immunol 174 4908-4915
[2]  
Lu H.(2015)Bat origin of human coronaviruses Virol J 12 221-1020
[3]  
Siddiqui P.(2005)SARS vaccine development Emerg Infect Dis 11 1016-454
[4]  
Zhou Y.(2003)Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 426 450-3201
[5]  
Jiang S.(2004)A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2 J Biol Chem 279 3197-6582
[6]  
Hu B.(2016)Bat severe acute respiratory syndrome-like coronavirus WIV1 encodes an extra accessory protein, ORFX, involved in modulation of the host immune response J Virol 90 6573-96
[7]  
Ge X.(2013)Identification of immunogenic determinants of the spike protein of SARS-like coronavirus Virol Sin 28 92-12128
[8]  
Wang L.F.(2007)Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies Proc Natl Acad Sci USA 104 12123-undefined
[9]  
Shi Z.(undefined)undefined undefined undefined undefined-undefined
[10]  
Jiang S.(undefined)undefined undefined undefined undefined-undefined